Hjem › Nyrekreft (nyrecellekarcinom)
Kliniske studier for Nyrekreft (nyrecellekarcinom) rekrutterer i USA
134 studier for Nyrekreft (nyrecellekarcinom) rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- Houston, TX35 studier
- New York City, NY27 studier
- Nashville, TN23 studier
- Dallas, TX23 studier
- St. Louis, MO23 studier
- Los Angeles, CA20 studier
- Boston, MA16 studier
- Baldwin Park, CA16 studier
- Philadelphia, PA15 studier
- Pittsburgh, PA15 studier
- Queens, NY15 studier
- Rochester, MN14 studier
- Cleveland, OH14 studier
- Jacksonville, FL14 studier
- San Diego, CA14 studier
- Washington, DC13 studier
- New Haven, CT13 studier
- Columbus, OH13 studier
- Durham, NC12 studier
- Omaha, NE12 studier
- Edison, NJ12 studier
- San Antonio, TX12 studier
- Ann Arbor, MI12 studier
- Phoenix, AZ11 studier
- Portland, OR11 studier
- San Francisco, CA11 studier
- Detroit, MI10 studier
- Baltimore, MD10 studier
- Grand Rapids, MI10 studier
- Atlanta, GA10 studier
- Arlington, VA9 studier
- Seattle, WA9 studier
- Aurora, CO9 studier
- Santa Monica, CA8 studier
- Charlotte, NC8 studier
- Milwaukee, WI8 studier
- Chicago, IL8 studier
- Miami, FL8 studier
- Oklahoma City, OK8 studier
- Denver, CO8 studier
Etter delstat
- Alabama7 studier
- Arizona22 studier
- Arkansas6 studier
- California51 studier
- Colorado15 studier
- Connecticut13 studier
- District of Columbia7 studier
- Florida31 studier
- Georgia12 studier
- Idaho4 studier
- Illinois14 studier
- Indiana8 studier
- Iowa9 studier
- Kansas5 studier
- Kentucky9 studier
- Louisiana7 studier
- Maine3 studier
- Maryland17 studier
- Massachusetts18 studier
- Michigan29 studier
- Minnesota20 studier
- Mississippi4 studier
- Missouri23 studier
- Montana3 studier
- Nebraska12 studier
- Nevada4 studier
- New Hampshire4 studier
- New Jersey16 studier
- New Mexico5 studier
- New York36 studier
- North Carolina19 studier
- North Dakota3 studier
- Ohio26 studier
- Oklahoma8 studier
- Oregon11 studier
- Pennsylvania26 studier
- Rhode Island6 studier
- South Carolina12 studier
- South Dakota4 studier
- Tennessee27 studier
- Texas56 studier
- Utah7 studier
- Vermont3 studier
- Virginia13 studier
- Washington12 studier
- West Virginia4 studier
- Wisconsin12 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT05536141Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07300241Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06265285A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06270706Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
RekruttererFase 2
Alder 18 til 120 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05155033A Phase 1 Study of the Safety and Tolerability of CTX-10726
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07419841Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
RekruttererFase 1/2
Alder 18 til 120 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07049926A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06234605Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05176483Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05287945The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07285044Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT03866382Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
RekruttererFase 2
Alder 12 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT04981509REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07594106DESTINY-PANTUMOUR04
RekruttererObservasjonsstudie
Alder 18 til 130 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07124000Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT04981119A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07489495Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma
RekruttererFase 1
Alder 18 til 100 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07748988Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06047379A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07293351Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06863311A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT07688187Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT05267626Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 18. sep. 2026 · NCT07828704Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.